Strategic Partnerships DxTerity has engaged in partnerships with Lupus Research Alliance and other organizations, signaling a path to collaborative research and potential co-branded diagnostic initiatives that can expand sales through joint programs and access to patient cohorts.

Product Expansion The launch of the IFN-1 Test for SLE demonstrates a willingness to broaden diagnostic offerings, suggesting opportunities to position additional assays or integrated testing panels to existing lupus and autoimmune patient populations.

Home & SMB Reach Previous collaborations with Amazon to distribute SARS-CoV-2 tests and the emphasis on at-home testing indicate channels and logistics capabilities that can be leveraged to reach small clinics, private practices, and direct-to-consumer segments.

Industry Credibility Strategic hires and high-profile partnerships bolster credibility in the autoimmune diagnostics space, supporting outreach efforts to larger healthcare purchasers and payers who require proven early adopters and measurable outcomes.

Financial Footing With revenue under $1M and a small team, there is room to tailor scalable value propositions focused on cost-effective, modular solutions for mid-market clinics and regional labs seeking innovative autoimmune testing at lower total cost of ownership.